skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: Database: IngentaConnect Open Access Journals remove Database: NORA - Norwegian Open Research Archives remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta‐analysis of observational studies with methodological considerations
Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta‐analysis of observational studies with methodological considerations
Material Type:
Article 		Add to My Research

Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta‐analysis of observational studies with methodological considerations

British journal of clinical pharmacology, 2021-10, Vol.87 (10), p.3890-3900 [Peer Reviewed Journal]

2021 The Authors. published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. ;2021 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. ;info:eu-repo/semantics/openAccess ;ISSN: 0306-5251 ;EISSN: 1365-2125 ;DOI: 10.1111/bcp.14805 ;PMID: 33783857

Full text available

Citations Cited by
2
Ondansetron use in nausea and vomiting during pregnancy: A descriptive analysis of prescription patterns and patient characteristics in UK general practice
Ondansetron use in nausea and vomiting during pregnancy: A descriptive analysis of prescription patterns and patient characteristics in UK general practice
Material Type:
Article 		Add to My Research

Ondansetron use in nausea and vomiting during pregnancy: A descriptive analysis of prescription patterns and patient characteristics in UK general practice

British journal of clinical pharmacology, 2022-10, Vol.88 (10), p.4526-4539 [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. ;2022 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. ;info:eu-repo/semantics/openAccess ;ISSN: 0306-5251 ;EISSN: 1365-2125 ;DOI: 10.1111/bcp.15370 ;PMID: 35483963

Full text available

Citations Cited by
3
An HPA-1a-positive platelet-depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-center, phase 1/2 proof-of-concept study
An HPA-1a-positive platelet-depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-center, phase 1/2 proof-of-concept study
Material Type:
Article 		Add to My Research

An HPA-1a-positive platelet-depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-center, phase 1/2 proof-of-concept study

Journal of thrombosis and haemostasis, 2023-04, Vol.21 (4), p.838 [Peer Reviewed Journal]

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;info:eu-repo/semantics/openAccess ;ISSN: 1538-7836 ;ISSN: 1538-7933 ;EISSN: 1538-7836 ;DOI: 10.1016/j.jtha.2022.11.041 ;PMID: 36696185

Digital Resources/Online E-Resources

Citations Cited by
4
Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome
Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome
Material Type:
Article 		Add to My Research

Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome

Medicine (Baltimore), 2017-03, Vol.96 (11) [Peer Reviewed Journal]

info:eu-repo/semantics/openAccess ;ISSN: 0025-7974 ;ISSN: 1536-5964 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000006338

Full text available

Citations Cited by
5
The prevalence of HPA‐1a alloimmunization and the potential risk of FNAIT depend on both the DRB301:01 allele and associated DR‐DQ haplotypes
The prevalence of HPA‐1a alloimmunization and the potential risk of FNAIT depend on both the DRB301:01 allele and associated DR‐DQ haplotypes
Material Type:
Article 		Add to My Research

The prevalence of HPA‐1a alloimmunization and the potential risk of FNAIT depend on both the DRB301:01 allele and associated DR‐DQ haplotypes

Scandinavian journal of immunology, 2020-07, Vol.92 (1), p.e12890-n/a [Peer Reviewed Journal]

2020 The Authors. published by John Wiley & Sons Ltd on behalf of The Scandinavian Foundation for Immunology ;2020 The Authors. Scandinavian Journal of Immunology published by John Wiley & Sons Ltd on behalf of The Scandinavian Foundation for Immunology. ;2020. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;ISSN: 0300-9475 ;ISSN: 1365-3083 ;EISSN: 1365-3083 ;DOI: 10.1111/sji.12890 ;PMID: 32299122

Digital Resources/Online E-Resources

Citations Cited by

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait